4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-22-000063
EVP, Quality & Ethics, and CPL acquired 11,826 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Glessner Coleen · EVP, Quality & Ethics, and CPL
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-08 | Grant or award : show line 1 in the form | +5,913 | 5,913 | D |
| 2022-04-08 | Grant or award : show line 2 in the form | +5,913 | 11,826 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-08 | Grant or award : show line 3 in the form Employee Stock Options (Right to Buy) | +23,651 | $42.28 | $999,964 | 23,651 | D |
Loading xslF345X03/wf-form4_164979397671420.xml…